Global Nucleic Acid Drugs Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Corrosion Under Insulation (CUI) Monitoring market size is predicted to grow from US$ 214 million in 2025 to US$ 260 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Corrosion under insulation (CUI) poses a significant operational loss, safety hazard and economic cost. Corrosion under insulation (CUI) is invisible to the surface of the insulation. Because of this, it is very difficult for conventional techniques to detect and monitor corrosion under insulation. The presence of moisture in and under insulation is the root cause of corrosion under insulation (CUI). Corrosion under insulation is a severe form of localized external corrosion that occurs in carbon and low alloy steel equipment that has been insulated. This form of corrosion occurs when water is absorbed by or collected in the insulation. As a result he equipment begins to corrode as it is exposed to water and oxygen. Depending on the structure and the location of the insulation, CUI can attack the jacketing, insulation hardware or underlying piping equipment. Additionally, when insulation becomes wet or absorbs moisture, its thermal insulating properties are drastically reduced. Because water conducts heat more efficiently than air, an aggressive corrosion cell is created where the trapped heat accelerates the rate of corrosion.
Global key players of Corrosion Under Insulation (CUI) Monitoring include Mistras, QSA Global, Inc. , Previan (Eddyfi), Kaefer Group, Alabama Specialty Products (Metal Samples) and Applied Technical Services, LLC, etc. The top six manufacturers hold a share over 65%.
LPI (LP Information)' newest research report, the “Corrosion Under Insulation (CUI) Monitoring Industry Forecast” looks at past sales and reviews total world Corrosion Under Insulation (CUI) Monitoring sales in 2024, providing a comprehensive analysis by region and market sector of projected Corrosion Under Insulation (CUI) Monitoring sales for 2025 through 2031. With Corrosion Under Insulation (CUI) Monitoring sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corrosion Under Insulation (CUI) Monitoring industry.
This Insight Report provides a comprehensive analysis of the global Corrosion Under Insulation (CUI) Monitoring landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Corrosion Under Insulation (CUI) Monitoring portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Corrosion Under Insulation (CUI) Monitoring market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corrosion Under Insulation (CUI) Monitoring and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corrosion Under Insulation (CUI) Monitoring.
This report presents a comprehensive overview, market shares, and growth opportunities of Corrosion Under Insulation (CUI) Monitoring market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Corrosion Under Insulation (CUI) Monitoring market size is predicted to grow from US$ 214 million in 2025 to US$ 260 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Corrosion under insulation (CUI) poses a significant operational loss, safety hazard and economic cost. Corrosion under insulation (CUI) is invisible to the surface of the insulation. Because of this, it is very difficult for conventional techniques to detect and monitor corrosion under insulation. The presence of moisture in and under insulation is the root cause of corrosion under insulation (CUI). Corrosion under insulation is a severe form of localized external corrosion that occurs in carbon and low alloy steel equipment that has been insulated. This form of corrosion occurs when water is absorbed by or collected in the insulation. As a result he equipment begins to corrode as it is exposed to water and oxygen. Depending on the structure and the location of the insulation, CUI can attack the jacketing, insulation hardware or underlying piping equipment. Additionally, when insulation becomes wet or absorbs moisture, its thermal insulating properties are drastically reduced. Because water conducts heat more efficiently than air, an aggressive corrosion cell is created where the trapped heat accelerates the rate of corrosion.
Global key players of Corrosion Under Insulation (CUI) Monitoring include Mistras, QSA Global, Inc. , Previan (Eddyfi), Kaefer Group, Alabama Specialty Products (Metal Samples) and Applied Technical Services, LLC, etc. The top six manufacturers hold a share over 65%.
LPI (LP Information)' newest research report, the “Corrosion Under Insulation (CUI) Monitoring Industry Forecast” looks at past sales and reviews total world Corrosion Under Insulation (CUI) Monitoring sales in 2024, providing a comprehensive analysis by region and market sector of projected Corrosion Under Insulation (CUI) Monitoring sales for 2025 through 2031. With Corrosion Under Insulation (CUI) Monitoring sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corrosion Under Insulation (CUI) Monitoring industry.
This Insight Report provides a comprehensive analysis of the global Corrosion Under Insulation (CUI) Monitoring landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Corrosion Under Insulation (CUI) Monitoring portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Corrosion Under Insulation (CUI) Monitoring market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corrosion Under Insulation (CUI) Monitoring and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corrosion Under Insulation (CUI) Monitoring.
This report presents a comprehensive overview, market shares, and growth opportunities of Corrosion Under Insulation (CUI) Monitoring market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Hardware
- Software
- Services
- Oil & Gas
- Marine
- Chemical & Petrochemical
- Energy & Power
- Food Processing Industries
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mistras
- QSA Global, Inc.
- Previan (Eddyfi)
- Kaefer Group
- Alabama Specialty Products (Metal Samples)
- Applied Technical Services, LLC
- Testex Inc
- Rohrback Cosasco Systems (RCS)
- 3-Sci Limited
- CorrosionRADAR
- iSensPro
- ESR Technology
- Maxwell NDT
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid Drugs Market Size (2020-2031)
2.1.2 Nucleic Acid Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nucleic Acid Drugs by Country/Region (2020, 2024 & 2031)
2.2 Nucleic Acid Drugs Segment by Type
2.2.1 Antisense Oligonucleotides (ASO)
2.2.2 siRNA
2.2.3 mRNA
2.3 Nucleic Acid Drugs Market Size by Type
2.3.1 Nucleic Acid Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nucleic Acid Drugs Market Size Market Share by Type (2020-2025)
2.4 Nucleic Acid Drugs Segment by Application
2.4.1 Neuromuscular Diseases
2.4.2 hATTR
2.4.3 COVID-19
2.4.4 Other
2.5 Nucleic Acid Drugs Market Size by Application
2.5.1 Nucleic Acid Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nucleic Acid Drugs Market Size Market Share by Application (2020-2025)
3 NUCLEIC ACID DRUGS MARKET SIZE BY PLAYER
3.1 Nucleic Acid Drugs Market Size Market Share by Player
3.1.1 Global Nucleic Acid Drugs Revenue by Player (2020-2025)
3.1.2 Global Nucleic Acid Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Nucleic Acid Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID DRUGS BY REGION
4.1 Nucleic Acid Drugs Market Size by Region (2020-2025)
4.2 Global Nucleic Acid Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nucleic Acid Drugs Market Size Growth (2020-2025)
4.4 APAC Nucleic Acid Drugs Market Size Growth (2020-2025)
4.5 Europe Nucleic Acid Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Nucleic Acid Drugs Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Nucleic Acid Drugs Market Size by Country (2020-2025)
5.2 Americas Nucleic Acid Drugs Market Size by Type (2020-2025)
5.3 Americas Nucleic Acid Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Drugs Market Size by Region (2020-2025)
6.2 APAC Nucleic Acid Drugs Market Size by Type (2020-2025)
6.3 APAC Nucleic Acid Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid Drugs Market Size by Country (2020-2025)
7.2 Europe Nucleic Acid Drugs Market Size by Type (2020-2025)
7.3 Europe Nucleic Acid Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid Drugs by Region (2020-2025)
8.2 Middle East & Africa Nucleic Acid Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Nucleic Acid Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID DRUGS MARKET FORECAST
10.1 Global Nucleic Acid Drugs Forecast by Region (2026-2031)
10.1.1 Global Nucleic Acid Drugs Forecast by Region (2026-2031)
10.1.2 Americas Nucleic Acid Drugs Forecast
10.1.3 APAC Nucleic Acid Drugs Forecast
10.1.4 Europe Nucleic Acid Drugs Forecast
10.1.5 Middle East & Africa Nucleic Acid Drugs Forecast
10.2 Americas Nucleic Acid Drugs Forecast by Country (2026-2031)
10.2.1 United States Market Nucleic Acid Drugs Forecast
10.2.2 Canada Market Nucleic Acid Drugs Forecast
10.2.3 Mexico Market Nucleic Acid Drugs Forecast
10.2.4 Brazil Market Nucleic Acid Drugs Forecast
10.3 APAC Nucleic Acid Drugs Forecast by Region (2026-2031)
10.3.1 China Nucleic Acid Drugs Market Forecast
10.3.2 Japan Market Nucleic Acid Drugs Forecast
10.3.3 Korea Market Nucleic Acid Drugs Forecast
10.3.4 Southeast Asia Market Nucleic Acid Drugs Forecast
10.3.5 India Market Nucleic Acid Drugs Forecast
10.3.6 Australia Market Nucleic Acid Drugs Forecast
10.4 Europe Nucleic Acid Drugs Forecast by Country (2026-2031)
10.4.1 Germany Market Nucleic Acid Drugs Forecast
10.4.2 France Market Nucleic Acid Drugs Forecast
10.4.3 UK Market Nucleic Acid Drugs Forecast
10.4.4 Italy Market Nucleic Acid Drugs Forecast
10.4.5 Russia Market Nucleic Acid Drugs Forecast
10.5 Middle East & Africa Nucleic Acid Drugs Forecast by Region (2026-2031)
10.5.1 Egypt Market Nucleic Acid Drugs Forecast
10.5.2 South Africa Market Nucleic Acid Drugs Forecast
10.5.3 Israel Market Nucleic Acid Drugs Forecast
10.5.4 Turkey Market Nucleic Acid Drugs Forecast
10.6 Global Nucleic Acid Drugs Forecast by Type (2026-2031)
10.7 Global Nucleic Acid Drugs Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nucleic Acid Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Information
11.1.2 Sarepta Therapeutics Nucleic Acid Drugs Product Offered
11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics Latest Developments
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Information
11.2.2 Ionis Pharmaceuticals Nucleic Acid Drugs Product Offered
11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Ionis Pharmaceuticals Main Business Overview
11.2.5 Ionis Pharmaceuticals Latest Developments
11.3 Alnylam
11.3.1 Alnylam Company Information
11.3.2 Alnylam Nucleic Acid Drugs Product Offered
11.3.3 Alnylam Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Alnylam Main Business Overview
11.3.5 Alnylam Latest Developments
11.4 Biogen
11.4.1 Biogen Company Information
11.4.2 Biogen Nucleic Acid Drugs Product Offered
11.4.3 Biogen Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Biogen Main Business Overview
11.4.5 Biogen Latest Developments
11.5 Nippon Shinyaku
11.5.1 Nippon Shinyaku Company Information
11.5.2 Nippon Shinyaku Nucleic Acid Drugs Product Offered
11.5.3 Nippon Shinyaku Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Nippon Shinyaku Main Business Overview
11.5.5 Nippon Shinyaku Latest Developments
11.6 Sobi
11.6.1 Sobi Company Information
11.6.2 Sobi Nucleic Acid Drugs Product Offered
11.6.3 Sobi Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Sobi Main Business Overview
11.6.5 Sobi Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Nucleic Acid Drugs Product Offered
11.7.3 Novartis Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 BioNTech
11.8.1 BioNTech Company Information
11.8.2 BioNTech Nucleic Acid Drugs Product Offered
11.8.3 BioNTech Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 BioNTech Main Business Overview
11.8.5 BioNTech Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Nucleic Acid Drugs Product Offered
11.9.3 Pfizer Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Information
11.10.2 Moderna Therapeutics Nucleic Acid Drugs Product Offered
11.10.3 Moderna Therapeutics Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Moderna Therapeutics Main Business Overview
11.10.5 Moderna Therapeutics Latest Developments
11.11 Jazz Pharmaceuticals
11.11.1 Jazz Pharmaceuticals Company Information
11.11.2 Jazz Pharmaceuticals Nucleic Acid Drugs Product Offered
11.11.3 Jazz Pharmaceuticals Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Jazz Pharmaceuticals Main Business Overview
11.11.5 Jazz Pharmaceuticals Latest Developments
11.12 CureVac
11.12.1 CureVac Company Information
11.12.2 CureVac Nucleic Acid Drugs Product Offered
11.12.3 CureVac Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 CureVac Main Business Overview
11.12.5 CureVac Latest Developments
11.13 Regulus Therapeutics
11.13.1 Regulus Therapeutics Company Information
11.13.2 Regulus Therapeutics Nucleic Acid Drugs Product Offered
11.13.3 Regulus Therapeutics Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Regulus Therapeutics Main Business Overview
11.13.5 Regulus Therapeutics Latest Developments
11.14 ProQR
11.14.1 ProQR Company Information
11.14.2 ProQR Nucleic Acid Drugs Product Offered
11.14.3 ProQR Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 ProQR Main Business Overview
11.14.5 ProQR Latest Developments
11.15 Secarna
11.15.1 Secarna Company Information
11.15.2 Secarna Nucleic Acid Drugs Product Offered
11.15.3 Secarna Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Secarna Main Business Overview
11.15.5 Secarna Latest Developments
11.16 MiNA Therapeutics
11.16.1 MiNA Therapeutics Company Information
11.16.2 MiNA Therapeutics Nucleic Acid Drugs Product Offered
11.16.3 MiNA Therapeutics Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 MiNA Therapeutics Main Business Overview
11.16.5 MiNA Therapeutics Latest Developments
11.17 Sylentis
11.17.1 Sylentis Company Information
11.17.2 Sylentis Nucleic Acid Drugs Product Offered
11.17.3 Sylentis Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Sylentis Main Business Overview
11.17.5 Sylentis Latest Developments
11.18 Arrowhead
11.18.1 Arrowhead Company Information
11.18.2 Arrowhead Nucleic Acid Drugs Product Offered
11.18.3 Arrowhead Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Arrowhead Main Business Overview
11.18.5 Arrowhead Latest Developments
11.19 Silence Therapeutics
11.19.1 Silence Therapeutics Company Information
11.19.2 Silence Therapeutics Nucleic Acid Drugs Product Offered
11.19.3 Silence Therapeutics Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Silence Therapeutics Main Business Overview
11.19.5 Silence Therapeutics Latest Developments
11.20 Dicerna
11.20.1 Dicerna Company Information
11.20.2 Dicerna Nucleic Acid Drugs Product Offered
11.20.3 Dicerna Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Dicerna Main Business Overview
11.20.5 Dicerna Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid Drugs Market Size (2020-2031)
2.1.2 Nucleic Acid Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nucleic Acid Drugs by Country/Region (2020, 2024 & 2031)
2.2 Nucleic Acid Drugs Segment by Type
2.2.1 Antisense Oligonucleotides (ASO)
2.2.2 siRNA
2.2.3 mRNA
2.3 Nucleic Acid Drugs Market Size by Type
2.3.1 Nucleic Acid Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nucleic Acid Drugs Market Size Market Share by Type (2020-2025)
2.4 Nucleic Acid Drugs Segment by Application
2.4.1 Neuromuscular Diseases
2.4.2 hATTR
2.4.3 COVID-19
2.4.4 Other
2.5 Nucleic Acid Drugs Market Size by Application
2.5.1 Nucleic Acid Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nucleic Acid Drugs Market Size Market Share by Application (2020-2025)
3 NUCLEIC ACID DRUGS MARKET SIZE BY PLAYER
3.1 Nucleic Acid Drugs Market Size Market Share by Player
3.1.1 Global Nucleic Acid Drugs Revenue by Player (2020-2025)
3.1.2 Global Nucleic Acid Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Nucleic Acid Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID DRUGS BY REGION
4.1 Nucleic Acid Drugs Market Size by Region (2020-2025)
4.2 Global Nucleic Acid Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nucleic Acid Drugs Market Size Growth (2020-2025)
4.4 APAC Nucleic Acid Drugs Market Size Growth (2020-2025)
4.5 Europe Nucleic Acid Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Nucleic Acid Drugs Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Nucleic Acid Drugs Market Size by Country (2020-2025)
5.2 Americas Nucleic Acid Drugs Market Size by Type (2020-2025)
5.3 Americas Nucleic Acid Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Drugs Market Size by Region (2020-2025)
6.2 APAC Nucleic Acid Drugs Market Size by Type (2020-2025)
6.3 APAC Nucleic Acid Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid Drugs Market Size by Country (2020-2025)
7.2 Europe Nucleic Acid Drugs Market Size by Type (2020-2025)
7.3 Europe Nucleic Acid Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid Drugs by Region (2020-2025)
8.2 Middle East & Africa Nucleic Acid Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Nucleic Acid Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID DRUGS MARKET FORECAST
10.1 Global Nucleic Acid Drugs Forecast by Region (2026-2031)
10.1.1 Global Nucleic Acid Drugs Forecast by Region (2026-2031)
10.1.2 Americas Nucleic Acid Drugs Forecast
10.1.3 APAC Nucleic Acid Drugs Forecast
10.1.4 Europe Nucleic Acid Drugs Forecast
10.1.5 Middle East & Africa Nucleic Acid Drugs Forecast
10.2 Americas Nucleic Acid Drugs Forecast by Country (2026-2031)
10.2.1 United States Market Nucleic Acid Drugs Forecast
10.2.2 Canada Market Nucleic Acid Drugs Forecast
10.2.3 Mexico Market Nucleic Acid Drugs Forecast
10.2.4 Brazil Market Nucleic Acid Drugs Forecast
10.3 APAC Nucleic Acid Drugs Forecast by Region (2026-2031)
10.3.1 China Nucleic Acid Drugs Market Forecast
10.3.2 Japan Market Nucleic Acid Drugs Forecast
10.3.3 Korea Market Nucleic Acid Drugs Forecast
10.3.4 Southeast Asia Market Nucleic Acid Drugs Forecast
10.3.5 India Market Nucleic Acid Drugs Forecast
10.3.6 Australia Market Nucleic Acid Drugs Forecast
10.4 Europe Nucleic Acid Drugs Forecast by Country (2026-2031)
10.4.1 Germany Market Nucleic Acid Drugs Forecast
10.4.2 France Market Nucleic Acid Drugs Forecast
10.4.3 UK Market Nucleic Acid Drugs Forecast
10.4.4 Italy Market Nucleic Acid Drugs Forecast
10.4.5 Russia Market Nucleic Acid Drugs Forecast
10.5 Middle East & Africa Nucleic Acid Drugs Forecast by Region (2026-2031)
10.5.1 Egypt Market Nucleic Acid Drugs Forecast
10.5.2 South Africa Market Nucleic Acid Drugs Forecast
10.5.3 Israel Market Nucleic Acid Drugs Forecast
10.5.4 Turkey Market Nucleic Acid Drugs Forecast
10.6 Global Nucleic Acid Drugs Forecast by Type (2026-2031)
10.7 Global Nucleic Acid Drugs Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nucleic Acid Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Information
11.1.2 Sarepta Therapeutics Nucleic Acid Drugs Product Offered
11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics Latest Developments
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Information
11.2.2 Ionis Pharmaceuticals Nucleic Acid Drugs Product Offered
11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Ionis Pharmaceuticals Main Business Overview
11.2.5 Ionis Pharmaceuticals Latest Developments
11.3 Alnylam
11.3.1 Alnylam Company Information
11.3.2 Alnylam Nucleic Acid Drugs Product Offered
11.3.3 Alnylam Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Alnylam Main Business Overview
11.3.5 Alnylam Latest Developments
11.4 Biogen
11.4.1 Biogen Company Information
11.4.2 Biogen Nucleic Acid Drugs Product Offered
11.4.3 Biogen Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Biogen Main Business Overview
11.4.5 Biogen Latest Developments
11.5 Nippon Shinyaku
11.5.1 Nippon Shinyaku Company Information
11.5.2 Nippon Shinyaku Nucleic Acid Drugs Product Offered
11.5.3 Nippon Shinyaku Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Nippon Shinyaku Main Business Overview
11.5.5 Nippon Shinyaku Latest Developments
11.6 Sobi
11.6.1 Sobi Company Information
11.6.2 Sobi Nucleic Acid Drugs Product Offered
11.6.3 Sobi Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Sobi Main Business Overview
11.6.5 Sobi Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Nucleic Acid Drugs Product Offered
11.7.3 Novartis Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 BioNTech
11.8.1 BioNTech Company Information
11.8.2 BioNTech Nucleic Acid Drugs Product Offered
11.8.3 BioNTech Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 BioNTech Main Business Overview
11.8.5 BioNTech Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Nucleic Acid Drugs Product Offered
11.9.3 Pfizer Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Information
11.10.2 Moderna Therapeutics Nucleic Acid Drugs Product Offered
11.10.3 Moderna Therapeutics Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Moderna Therapeutics Main Business Overview
11.10.5 Moderna Therapeutics Latest Developments
11.11 Jazz Pharmaceuticals
11.11.1 Jazz Pharmaceuticals Company Information
11.11.2 Jazz Pharmaceuticals Nucleic Acid Drugs Product Offered
11.11.3 Jazz Pharmaceuticals Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Jazz Pharmaceuticals Main Business Overview
11.11.5 Jazz Pharmaceuticals Latest Developments
11.12 CureVac
11.12.1 CureVac Company Information
11.12.2 CureVac Nucleic Acid Drugs Product Offered
11.12.3 CureVac Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 CureVac Main Business Overview
11.12.5 CureVac Latest Developments
11.13 Regulus Therapeutics
11.13.1 Regulus Therapeutics Company Information
11.13.2 Regulus Therapeutics Nucleic Acid Drugs Product Offered
11.13.3 Regulus Therapeutics Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Regulus Therapeutics Main Business Overview
11.13.5 Regulus Therapeutics Latest Developments
11.14 ProQR
11.14.1 ProQR Company Information
11.14.2 ProQR Nucleic Acid Drugs Product Offered
11.14.3 ProQR Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 ProQR Main Business Overview
11.14.5 ProQR Latest Developments
11.15 Secarna
11.15.1 Secarna Company Information
11.15.2 Secarna Nucleic Acid Drugs Product Offered
11.15.3 Secarna Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Secarna Main Business Overview
11.15.5 Secarna Latest Developments
11.16 MiNA Therapeutics
11.16.1 MiNA Therapeutics Company Information
11.16.2 MiNA Therapeutics Nucleic Acid Drugs Product Offered
11.16.3 MiNA Therapeutics Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 MiNA Therapeutics Main Business Overview
11.16.5 MiNA Therapeutics Latest Developments
11.17 Sylentis
11.17.1 Sylentis Company Information
11.17.2 Sylentis Nucleic Acid Drugs Product Offered
11.17.3 Sylentis Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Sylentis Main Business Overview
11.17.5 Sylentis Latest Developments
11.18 Arrowhead
11.18.1 Arrowhead Company Information
11.18.2 Arrowhead Nucleic Acid Drugs Product Offered
11.18.3 Arrowhead Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Arrowhead Main Business Overview
11.18.5 Arrowhead Latest Developments
11.19 Silence Therapeutics
11.19.1 Silence Therapeutics Company Information
11.19.2 Silence Therapeutics Nucleic Acid Drugs Product Offered
11.19.3 Silence Therapeutics Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Silence Therapeutics Main Business Overview
11.19.5 Silence Therapeutics Latest Developments
11.20 Dicerna
11.20.1 Dicerna Company Information
11.20.2 Dicerna Nucleic Acid Drugs Product Offered
11.20.3 Dicerna Nucleic Acid Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Dicerna Main Business Overview
11.20.5 Dicerna Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nucleic Acid Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nucleic Acid Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antisense Oligonucleotides (ASO)
Table 4. Major Players of siRNA
Table 5. Major Players of mRNA
Table 6. Nucleic Acid Drugs Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Nucleic Acid Drugs Market Size byType (2020-2025) & ($ millions)
Table 8. Global Nucleic Acid Drugs Market Size Market Share byType (2020-2025)
Table 9. Nucleic Acid Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Nucleic Acid Drugs Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Nucleic Acid Drugs Market Size Market Share by Application (2020-2025)
Table 12. Global Nucleic Acid Drugs Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Nucleic Acid Drugs Revenue Market Share by Player (2020-2025)
Table 14. Nucleic Acid Drugs Key Players Head office and Products Offered
Table 15. Nucleic Acid Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nucleic Acid Drugs Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Nucleic Acid Drugs Market Size Market Share by Region (2020-2025)
Table 20. Global Nucleic Acid Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Nucleic Acid Drugs Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Nucleic Acid Drugs Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Nucleic Acid Drugs Market Size Market Share by Country (2020-2025)
Table 24. Americas Nucleic Acid Drugs Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Nucleic Acid Drugs Market Size Market Share byType (2020-2025)
Table 26. Americas Nucleic Acid Drugs Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Nucleic Acid Drugs Market Size Market Share by Application (2020-2025)
Table 28. APAC Nucleic Acid Drugs Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Nucleic Acid Drugs Market Size Market Share by Region (2020-2025)
Table 30. APAC Nucleic Acid Drugs Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Nucleic Acid Drugs Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Nucleic Acid Drugs Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Nucleic Acid Drugs Market Size Market Share by Country (2020-2025)
Table 34. Europe Nucleic Acid Drugs Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Nucleic Acid Drugs Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Nucleic Acid Drugs Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Nucleic Acid Drugs Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Nucleic Acid Drugs Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Nucleic Acid Drugs
Table 40. Key Market Challenges & Risks of Nucleic Acid Drugs
Table 41. Key IndustryTrends of Nucleic Acid Drugs
Table 42. Global Nucleic Acid Drugs Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Nucleic Acid Drugs Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Nucleic Acid Drugs Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Nucleic Acid Drugs Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. SareptaTherapeutics Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 47. SareptaTherapeutics Nucleic Acid Drugs Product Offered
Table 48. SareptaTherapeutics Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. SareptaTherapeutics Main Business
Table 50. SareptaTherapeutics Latest Developments
Table 51. Ionis Pharmaceuticals Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 52. Ionis Pharmaceuticals Nucleic Acid Drugs Product Offered
Table 53. Ionis Pharmaceuticals Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Ionis Pharmaceuticals Main Business
Table 55. Ionis Pharmaceuticals Latest Developments
Table 56. Alnylam Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 57. Alnylam Nucleic Acid Drugs Product Offered
Table 58. Alnylam Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Alnylam Main Business
Table 60. Alnylam Latest Developments
Table 61. Biogen Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 62. Biogen Nucleic Acid Drugs Product Offered
Table 63. Biogen Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Biogen Main Business
Table 65. Biogen Latest Developments
Table 66. Nippon Shinyaku Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 67. Nippon Shinyaku Nucleic Acid Drugs Product Offered
Table 68. Nippon Shinyaku Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Nippon Shinyaku Main Business
Table 70. Nippon Shinyaku Latest Developments
Table 71. Sobi Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 72. Sobi Nucleic Acid Drugs Product Offered
Table 73. Sobi Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Sobi Main Business
Table 75. Sobi Latest Developments
Table 76. Novartis Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 77. Novartis Nucleic Acid Drugs Product Offered
Table 78. Novartis Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. BioNTech Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 82. BioNTech Nucleic Acid Drugs Product Offered
Table 83. BioNTech Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. BioNTech Main Business
Table 85. BioNTech Latest Developments
Table 86. Pfizer Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 87. Pfizer Nucleic Acid Drugs Product Offered
Table 88. Pfizer Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. ModernaTherapeutics Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 92. ModernaTherapeutics Nucleic Acid Drugs Product Offered
Table 93. ModernaTherapeutics Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. ModernaTherapeutics Main Business
Table 95. ModernaTherapeutics Latest Developments
Table 96. Jazz Pharmaceuticals Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 97. Jazz Pharmaceuticals Nucleic Acid Drugs Product Offered
Table 98. Jazz Pharmaceuticals Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Jazz Pharmaceuticals Main Business
Table 100. Jazz Pharmaceuticals Latest Developments
Table 101. CureVac Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 102. CureVac Nucleic Acid Drugs Product Offered
Table 103. CureVac Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. CureVac Main Business
Table 105. CureVac Latest Developments
Table 106. RegulusTherapeutics Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 107. RegulusTherapeutics Nucleic Acid Drugs Product Offered
Table 108. RegulusTherapeutics Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. RegulusTherapeutics Main Business
Table 110. RegulusTherapeutics Latest Developments
Table 111. ProQR Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 112. ProQR Nucleic Acid Drugs Product Offered
Table 113. ProQR Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. ProQR Main Business
Table 115. ProQR Latest Developments
Table 116. Secarna Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 117. Secarna Nucleic Acid Drugs Product Offered
Table 118. Secarna Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Secarna Main Business
Table 120. Secarna Latest Developments
Table 121. MiNATherapeutics Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 122. MiNATherapeutics Nucleic Acid Drugs Product Offered
Table 123. MiNATherapeutics Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. MiNATherapeutics Main Business
Table 125. MiNATherapeutics Latest Developments
Table 126. Sylentis Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 127. Sylentis Nucleic Acid Drugs Product Offered
Table 128. Sylentis Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Sylentis Main Business
Table 130. Sylentis Latest Developments
Table 131. Arrowhead Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 132. Arrowhead Nucleic Acid Drugs Product Offered
Table 133. Arrowhead Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Arrowhead Main Business
Table 135. Arrowhead Latest Developments
Table 136. SilenceTherapeutics Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 137. SilenceTherapeutics Nucleic Acid Drugs Product Offered
Table 138. SilenceTherapeutics Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. SilenceTherapeutics Main Business
Table 140. SilenceTherapeutics Latest Developments
Table 141. Dicerna Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 142. Dicerna Nucleic Acid Drugs Product Offered
Table 143. Dicerna Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Dicerna Main Business
Table 145. Dicerna Latest Developments
Table 1. Nucleic Acid Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nucleic Acid Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antisense Oligonucleotides (ASO)
Table 4. Major Players of siRNA
Table 5. Major Players of mRNA
Table 6. Nucleic Acid Drugs Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Nucleic Acid Drugs Market Size byType (2020-2025) & ($ millions)
Table 8. Global Nucleic Acid Drugs Market Size Market Share byType (2020-2025)
Table 9. Nucleic Acid Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Nucleic Acid Drugs Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Nucleic Acid Drugs Market Size Market Share by Application (2020-2025)
Table 12. Global Nucleic Acid Drugs Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Nucleic Acid Drugs Revenue Market Share by Player (2020-2025)
Table 14. Nucleic Acid Drugs Key Players Head office and Products Offered
Table 15. Nucleic Acid Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nucleic Acid Drugs Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Nucleic Acid Drugs Market Size Market Share by Region (2020-2025)
Table 20. Global Nucleic Acid Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Nucleic Acid Drugs Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Nucleic Acid Drugs Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Nucleic Acid Drugs Market Size Market Share by Country (2020-2025)
Table 24. Americas Nucleic Acid Drugs Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Nucleic Acid Drugs Market Size Market Share byType (2020-2025)
Table 26. Americas Nucleic Acid Drugs Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Nucleic Acid Drugs Market Size Market Share by Application (2020-2025)
Table 28. APAC Nucleic Acid Drugs Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Nucleic Acid Drugs Market Size Market Share by Region (2020-2025)
Table 30. APAC Nucleic Acid Drugs Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Nucleic Acid Drugs Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Nucleic Acid Drugs Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Nucleic Acid Drugs Market Size Market Share by Country (2020-2025)
Table 34. Europe Nucleic Acid Drugs Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Nucleic Acid Drugs Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Nucleic Acid Drugs Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Nucleic Acid Drugs Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Nucleic Acid Drugs Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Nucleic Acid Drugs
Table 40. Key Market Challenges & Risks of Nucleic Acid Drugs
Table 41. Key IndustryTrends of Nucleic Acid Drugs
Table 42. Global Nucleic Acid Drugs Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Nucleic Acid Drugs Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Nucleic Acid Drugs Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Nucleic Acid Drugs Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. SareptaTherapeutics Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 47. SareptaTherapeutics Nucleic Acid Drugs Product Offered
Table 48. SareptaTherapeutics Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. SareptaTherapeutics Main Business
Table 50. SareptaTherapeutics Latest Developments
Table 51. Ionis Pharmaceuticals Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 52. Ionis Pharmaceuticals Nucleic Acid Drugs Product Offered
Table 53. Ionis Pharmaceuticals Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Ionis Pharmaceuticals Main Business
Table 55. Ionis Pharmaceuticals Latest Developments
Table 56. Alnylam Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 57. Alnylam Nucleic Acid Drugs Product Offered
Table 58. Alnylam Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Alnylam Main Business
Table 60. Alnylam Latest Developments
Table 61. Biogen Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 62. Biogen Nucleic Acid Drugs Product Offered
Table 63. Biogen Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Biogen Main Business
Table 65. Biogen Latest Developments
Table 66. Nippon Shinyaku Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 67. Nippon Shinyaku Nucleic Acid Drugs Product Offered
Table 68. Nippon Shinyaku Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Nippon Shinyaku Main Business
Table 70. Nippon Shinyaku Latest Developments
Table 71. Sobi Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 72. Sobi Nucleic Acid Drugs Product Offered
Table 73. Sobi Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Sobi Main Business
Table 75. Sobi Latest Developments
Table 76. Novartis Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 77. Novartis Nucleic Acid Drugs Product Offered
Table 78. Novartis Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. BioNTech Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 82. BioNTech Nucleic Acid Drugs Product Offered
Table 83. BioNTech Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. BioNTech Main Business
Table 85. BioNTech Latest Developments
Table 86. Pfizer Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 87. Pfizer Nucleic Acid Drugs Product Offered
Table 88. Pfizer Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. ModernaTherapeutics Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 92. ModernaTherapeutics Nucleic Acid Drugs Product Offered
Table 93. ModernaTherapeutics Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. ModernaTherapeutics Main Business
Table 95. ModernaTherapeutics Latest Developments
Table 96. Jazz Pharmaceuticals Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 97. Jazz Pharmaceuticals Nucleic Acid Drugs Product Offered
Table 98. Jazz Pharmaceuticals Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Jazz Pharmaceuticals Main Business
Table 100. Jazz Pharmaceuticals Latest Developments
Table 101. CureVac Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 102. CureVac Nucleic Acid Drugs Product Offered
Table 103. CureVac Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. CureVac Main Business
Table 105. CureVac Latest Developments
Table 106. RegulusTherapeutics Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 107. RegulusTherapeutics Nucleic Acid Drugs Product Offered
Table 108. RegulusTherapeutics Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. RegulusTherapeutics Main Business
Table 110. RegulusTherapeutics Latest Developments
Table 111. ProQR Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 112. ProQR Nucleic Acid Drugs Product Offered
Table 113. ProQR Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. ProQR Main Business
Table 115. ProQR Latest Developments
Table 116. Secarna Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 117. Secarna Nucleic Acid Drugs Product Offered
Table 118. Secarna Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Secarna Main Business
Table 120. Secarna Latest Developments
Table 121. MiNATherapeutics Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 122. MiNATherapeutics Nucleic Acid Drugs Product Offered
Table 123. MiNATherapeutics Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. MiNATherapeutics Main Business
Table 125. MiNATherapeutics Latest Developments
Table 126. Sylentis Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 127. Sylentis Nucleic Acid Drugs Product Offered
Table 128. Sylentis Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Sylentis Main Business
Table 130. Sylentis Latest Developments
Table 131. Arrowhead Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 132. Arrowhead Nucleic Acid Drugs Product Offered
Table 133. Arrowhead Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Arrowhead Main Business
Table 135. Arrowhead Latest Developments
Table 136. SilenceTherapeutics Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 137. SilenceTherapeutics Nucleic Acid Drugs Product Offered
Table 138. SilenceTherapeutics Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. SilenceTherapeutics Main Business
Table 140. SilenceTherapeutics Latest Developments
Table 141. Dicerna Details, CompanyType, Nucleic Acid Drugs Area Served and Its Competitors
Table 142. Dicerna Nucleic Acid Drugs Product Offered
Table 143. Dicerna Nucleic Acid Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Dicerna Main Business
Table 145. Dicerna Latest Developments
LIST OF FIGURES
Figure 1. Nucleic Acid Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nucleic Acid Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nucleic Acid Drugs Sales Market Share by Country/Region (2024)
Figure 8. Nucleic Acid Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nucleic Acid Drugs Market Size Market Share byType in 2024
Figure 10. Nucleic Acid Drugs in Neuromuscular Diseases
Figure 11. Global Nucleic Acid Drugs Market: Neuromuscular Diseases (2020-2025) & ($ millions)
Figure 12. Nucleic Acid Drugs in hATTR
Figure 13. Global Nucleic Acid Drugs Market: hATTR (2020-2025) & ($ millions)
Figure 14. Nucleic Acid Drugs in COVID-19
Figure 15. Global Nucleic Acid Drugs Market: COVID-19 (2020-2025) & ($ millions)
Figure 16. Nucleic Acid Drugs in Other
Figure 17. Global Nucleic Acid Drugs Market: Other (2020-2025) & ($ millions)
Figure 18. Global Nucleic Acid Drugs Market Size Market Share by Application in 2024
Figure 19. Global Nucleic Acid Drugs Revenue Market Share by Player in 2024
Figure 20. Global Nucleic Acid Drugs Market Size Market Share by Region (2020-2025)
Figure 21. Americas Nucleic Acid Drugs Market Size 2020-2025 ($ millions)
Figure 22. APAC Nucleic Acid Drugs Market Size 2020-2025 ($ millions)
Figure 23. Europe Nucleic Acid Drugs Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Nucleic Acid Drugs Market Size 2020-2025 ($ millions)
Figure 25. Americas Nucleic Acid Drugs Value Market Share by Country in 2024
Figure 26. United States Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Nucleic Acid Drugs Market Size Market Share by Region in 2024
Figure 31. APAC Nucleic Acid Drugs Market Size Market Share byType (2020-2025)
Figure 32. APAC Nucleic Acid Drugs Market Size Market Share by Application (2020-2025)
Figure 33. China Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 37. India Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Nucleic Acid Drugs Market Size Market Share by Country in 2024
Figure 40. Europe Nucleic Acid Drugs Market Size Market Share byType (2020-2025)
Figure 41. Europe Nucleic Acid Drugs Market Size Market Share by Application (2020-2025)
Figure 42. Germany Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43.France Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Nucleic Acid Drugs Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Nucleic Acid Drugs Market Size Market Share byType (2020-2025)
Figure 49. Middle East & Africa Nucleic Acid Drugs Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 53.Turkey Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 56. APAC Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 57. Europe Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 59. United States Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 60. Canada Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 61. Mexico Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 62. Brazil Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 63. China Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 64. Japan Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 65. Korea Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 67. India Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 68. Australia Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 69. Germany Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 70.France Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 71. UK Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 72. Italy Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 73. Russia Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 74. Egypt Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 75. South Africa Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 76. Israel Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 77.Turkey Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 78. Global Nucleic Acid Drugs Market Size Market ShareForecast byType (2026-2031)
Figure 79. Global Nucleic Acid Drugs Market Size Market ShareForecast by Application (2026-2031)
Figure 80. GCC Countries Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 1. Nucleic Acid Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nucleic Acid Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nucleic Acid Drugs Sales Market Share by Country/Region (2024)
Figure 8. Nucleic Acid Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nucleic Acid Drugs Market Size Market Share byType in 2024
Figure 10. Nucleic Acid Drugs in Neuromuscular Diseases
Figure 11. Global Nucleic Acid Drugs Market: Neuromuscular Diseases (2020-2025) & ($ millions)
Figure 12. Nucleic Acid Drugs in hATTR
Figure 13. Global Nucleic Acid Drugs Market: hATTR (2020-2025) & ($ millions)
Figure 14. Nucleic Acid Drugs in COVID-19
Figure 15. Global Nucleic Acid Drugs Market: COVID-19 (2020-2025) & ($ millions)
Figure 16. Nucleic Acid Drugs in Other
Figure 17. Global Nucleic Acid Drugs Market: Other (2020-2025) & ($ millions)
Figure 18. Global Nucleic Acid Drugs Market Size Market Share by Application in 2024
Figure 19. Global Nucleic Acid Drugs Revenue Market Share by Player in 2024
Figure 20. Global Nucleic Acid Drugs Market Size Market Share by Region (2020-2025)
Figure 21. Americas Nucleic Acid Drugs Market Size 2020-2025 ($ millions)
Figure 22. APAC Nucleic Acid Drugs Market Size 2020-2025 ($ millions)
Figure 23. Europe Nucleic Acid Drugs Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Nucleic Acid Drugs Market Size 2020-2025 ($ millions)
Figure 25. Americas Nucleic Acid Drugs Value Market Share by Country in 2024
Figure 26. United States Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Nucleic Acid Drugs Market Size Market Share by Region in 2024
Figure 31. APAC Nucleic Acid Drugs Market Size Market Share byType (2020-2025)
Figure 32. APAC Nucleic Acid Drugs Market Size Market Share by Application (2020-2025)
Figure 33. China Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 37. India Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Nucleic Acid Drugs Market Size Market Share by Country in 2024
Figure 40. Europe Nucleic Acid Drugs Market Size Market Share byType (2020-2025)
Figure 41. Europe Nucleic Acid Drugs Market Size Market Share by Application (2020-2025)
Figure 42. Germany Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43.France Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Nucleic Acid Drugs Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Nucleic Acid Drugs Market Size Market Share byType (2020-2025)
Figure 49. Middle East & Africa Nucleic Acid Drugs Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 53.Turkey Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Nucleic Acid Drugs Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 56. APAC Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 57. Europe Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 59. United States Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 60. Canada Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 61. Mexico Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 62. Brazil Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 63. China Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 64. Japan Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 65. Korea Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 67. India Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 68. Australia Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 69. Germany Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 70.France Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 71. UK Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 72. Italy Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 73. Russia Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 74. Egypt Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 75. South Africa Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 76. Israel Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 77.Turkey Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
Figure 78. Global Nucleic Acid Drugs Market Size Market ShareForecast byType (2026-2031)
Figure 79. Global Nucleic Acid Drugs Market Size Market ShareForecast by Application (2026-2031)
Figure 80. GCC Countries Nucleic Acid Drugs Market Size 2026-2031 ($ millions)
More Publications
Global Public Safety Security Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
103 pages
Global Wireless IoT Sensors Market Growth 2025-2031
US$ 3,660.00
January 2025
137 pages
Global Oracle Application Service Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
101 pages
Global Functional and Testing Sofware Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
123 pages
Global Magneto Elastictorque Sensor Market Growth 2025-2031
US$ 3,660.00
November 2025
91 pages
